Blood test may predict dangerous drop in platelets for brain cancer patients

This study involved 244 adults with newly diagnosed glioblastoma who were receiving standard chemoradiation (Stupp protocol). Researchers tracked platelet counts during treatment to see if changes could predict which patients would later develop dangerously low platelets (thrombocytopenia). The goal was to create a monitoring plan to catch this risk early. The study did not test a new treatment, but aimed to improve safety during existing therapy.